msGUIDE – Insight into Drug Distribution and Local Concentration using Multispectral Imanging of Fluorescent Drugs in Inflammatory Bowel Diseases

Insight into Drug Distribution and Local Concentration using Multispectral
Imaging of Fluorescent Drugs in Inflammatory Bowel Diseases

Limitations to personalized medicine

2.5 Million patients in Europe suffer from inflammatory bowel diseases (IBD) but limitations of current technology do not allow targeted biological treatment .
Read more...

5 Partners, 4 Countries

The msGUIDE interdisciplinary consortium integrates expertise in medical device development and clinical translation.
Read more...

The msGUIDE solution

msGUIDE will develop a groundbreaking technology that will visualize and quantify local drug concentrations in the colon to gain insight into drug distribution.
Read more...

UMCG1-removebg-preview

645-erasmus-mc-removebg-preview

Logotyp LaNova průhledný

Previous

Next

Latest Tweets

Tweets by msGUIDE

Recent Posts

msGUIDE coordinator speaking at the Thessaloniki International Fair (TIF2024)
The msGUIDE coordinator Dimitris Gorpas gave a talk at the Thessaloniki International Fair 2024 about >Fluorescence Molecular Imaging, through it’s …Read More »
msGUIDE at the Thessaloniki International Fair (TIF2024)
The msGUIDE team was present at the Thessaloniki International Fair (TIF2024) at the stand B41 Helmholtz Munich in the German …Read More »
msGUIDE fluorescence standards publication featured by JBO
Our msGUIDE study on standardization and benchmarking of FMI systems is featured by the Journal of Biomedical Optics! Read the …Read More »
World IBD Day 19th May 2023
Today is World IBD Day 2023 and we at msGUIDE want to support raising awarenesss for the millions of people …Read More »
msGUIDE at the Digestive Disease Week, Chicago
UMCG introduced msGUIDE and the work on fluorescently labelled drugs distribution and target cells in patients with inflammatory bowel disease …Read More »

Events Calendar